Ahlholm P, Sipilä K, Vallittu P, Kotiranta U, Lappalainen R Accuracy of inlay and onlay restorations based on 3D printing or milling technique - a pilot study. Eur J Prosthodont Restor Dent. 2019 May 30;27(2):56-64. doi: 10.1922/EJPRD_01814Ahlholm09.
Alharbi N, Wismeijer D, Osman RB Additive Manufacturing Techniques in Prosthodontics: Where Do We Currently Stand? A Critical Review. Int J Prosthodont. 2017 September/October;30(5):474-484. doi: 10.11607/ijp.5079. Epub 2017 Jul 27. Review.
Baratieri LN, Canabarro S, Lopes GC, Ritter AV Effect of resin viscosity and enamel beveling on the clinical performance of Class V composite restorations: three-year results. Oper Dent. 2003 Sep-Oct;28(5):482-7.
Beuer F, Schweiger J, Edelhoff D Digital dentistry: an overview of recent developments for CAD/CAM generated restorations. Br Dent J. 2008 May 10;204(9):505-11. doi: 10.1038/sj.bdj.2008.350. Review.
Eftekhar Ashtiani R, Nasiri Khanlar L, Mahshid M, Moshaverinia A Comparison of dimensional accuracy of conventionally and digitally manufactured intracoronal restorations. J Prosthet Dent. 2018 Feb;119(2):233-238. doi: 10.1016/j.prosdent.2017.03.014. Epub 2017 Jun 2.
Garoushi S, Gargoum A, Vallittu PK, Lassila L Short fiber-reinforced composite restorations: A review of the current literature. J Investig Clin Dent. 2018 Aug;9(3):e12330. doi: 10.1111/jicd.12330. Epub 2018 Feb 25. Review.
Leinfelder KF Evaluation of criteria used for assessing the clinical performance of composite resins in posterior teeth. Quintessence Int. 1987 Aug;18(8):531-6.
Mai HN, Lee KB, Lee DH Fit of interim crowns fabricated using photopolymer-jetting 3D printing. J Prosthet Dent. 2017 Aug;118(2):208-215. doi: 10.1016/j.prosdent.2016.10.030. Epub 2017 Jan 12.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
